BioNTech is a biotechnology company based in Germany, known for developing and manufacturing immunotherapies for cancer and infectious diseases. The company gained significant recognition for its role in creating one of the first effective COVID-19 vaccines in collaboration with Pfizer. Founded in 2008, BioNTech focuses on personalized medicine and utilizes messenger RNA (mRNA) technology to trigger immune responses against specific diseases. The company’s innovative approach has positioned it as a leader in the field of biopharmaceuticals, particularly in the development of novel therapeutic solutions.
BioNTechov uspjeh mRNA vakcine prelazi u novu fazu usredotočujući se na terapije za rak. Tvrtka je izvijestila o padu dobiti po dionici na 1,08 eura, ali je nadmašila tržišna očekivanja.…